Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AFLAC ( (AFL) ) has shared an update.
On November 4, 2025, Aflac Incorporated announced its third quarter financial results, reporting a substantial increase in net earnings to $1.6 billion compared to a net loss in the previous year. This improvement was driven by net investment gains and a favorable yen/dollar exchange rate. The company also declared a fourth quarter dividend and continued its share repurchase program. Aflac Japan saw a notable increase in sales due to strong performance of its cancer insurance product, while Aflac U.S. experienced growth in net earned premiums and sales, particularly in group life and disability products.
The most recent analyst rating on (AFL) stock is a Hold with a $118.00 price target. To see the full list of analyst forecasts on AFLAC stock, see the AFL Stock Forecast page.
Spark’s Take on AFL Stock
According to Spark, TipRanks’ AI Analyst, AFL is a Neutral.
AFLAC’s overall stock score of 68 reflects a stable financial position with strong cash flow and profitability. The earnings call provided positive insights into sales growth and shareholder returns, although technical indicators suggest limited momentum. Valuation concerns due to a high P/E ratio are balanced by a decent dividend yield.
To see Spark’s full report on AFL stock, click here.
More about AFLAC
Aflac Incorporated operates in the insurance industry, primarily offering supplemental insurance products such as cancer insurance, life insurance, and disability insurance. The company has a significant market presence in both the United States and Japan, focusing on providing financial protection products to a diverse customer base.
Average Trading Volume: 2,304,332
Technical Sentiment Signal: Strong Buy
Current Market Cap: $57.21B
For an in-depth examination of AFL stock, go to TipRanks’ Overview page.